Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

FDA Update: Anti-CD20 Antibody Granted Accelerated Approval for CLL
Tracy Hampton, PhD, MDLinx Oncology
Congress Proposes SGR Fix
Roberta Buell, MBA, Sausalito Healthcare Partners
Technology Advances: Radiosurgery Trial Sparks Optimism for Early Lung Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
  See all

Articles: Gynecologic Oncology



Latest (3) Month's Top Read  
Receive free subspecialty "5-minute updates" via email
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix
British Journal of Cancer, 11/20/09
Sponsor
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma
British Journal of Cancer, 11/20/09
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring
British Journal of Cancer, 11/20/09

Prior Articles


Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors
Journal of Clinical Oncology, 11/19/09
Minimal deviation mucinous adenocarcinoma (adenoma malignum) of the uterine corpus
Pathology International, 11/19/09
Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue
Virchows Archiv, 11/19/09
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort
Virchows Archiv, 11/17/09
Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma
Oncology (Karger), 11/17/09
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
Annals of Oncology, 11/17/09
Exclusive Author Commentary
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
Annals of Oncology, 11/16/09
APC promoter hypermethylation is an early event in endometrial tumorigenesis
Cancer Science, 11/16/09
Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas
Cancer Science, 11/16/09
Relationship between NFKB1 –94 insertion/deletion ATTG polymorphism and susceptibility of cervical squamous cell carcinoma risk
Annals of Oncology, 11/16/09
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Journal of Clinical Oncology, 11/13/09
Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer
Anticancer Research, 11/13/09
Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype
American Journal of Epidemiology, 11/13/09
Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer
British Journal of Cancer, 11/13/09
Cooperation of decay-accelerating factor and membrane cofactor protein in regulating survival of human cervical cancer cells
BMC Cancer, 11/13/09    Free full text
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
British Journal of Cancer, 11/13/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
1      2      3      4      5      6      7      8      9      10      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.